Skip To Main Content

Questions?1-833-393-4363

Helpful resources

We’re with you every step of the way

Downloadable resources

Take advantage of these downloadable resources to help you stay on track with your treatment.

PATIENT BROCHURE

DME patient brochure image

The patient brochure contains important information about DME and VABYSMO to help you get the most out of your treatment.

Download Patient Brochure

Descargar el folleto en español

Download Patient Brochure

Descargar el folleto en español

AMSLER GRID

An Amsler grid is a simple test that can help you monitor your vision at home. It is used to check whether you see blurry, distorted, or wavy lines, missing corners, and dark or blank spots.

Download Amsler Grid

Download Amsler Grid

Sign up for support to receive helpful information about DME and treatment with VABYSMO^®

Support organizations

These organizations offer information and support for people living with DME.

Committed to helping people with all types of diabetes live happier, healthier, and more hopeful lives, diaTribe has deep insights into the patient experience and closely covers the latest research, treatments, and initiatives in diabetes, as well as influences the national conversation.

For 83 years, the ADA has driven discovery and research to treat, manage, and prevent diabetes while working relentlessly for a cure. The ADA is the nation’s leading voluntary health organization fighting to bend the curve on the diabetes epidemic.

Guided by the belief that every person with diabetes has the right to live a healthy, happy, and productive life, Taking Control Of Your Diabetes^® educates and motivates people with diabetes to take a more active role in their condition and provides innovative and integrative continuing education to medical professionals caring for people with diabetes.

preventblindness.org

Prevent Blindness is the nation’s leading volunteer eye health and safety organization, dedicated to preventing blindness and preserving sight. Prevent Blindness promotes access to eye care, education, empowerment, and support for those with vision loss due to eye disease.

JDRF is leading the fight against type 1 diabetes (T1D) by funding research, advocating for policies that accelerate access to new therapies, and providing a support network for millions of people around the world impacted by T1D.

This information is provided as a resource for you. We do not endorse or show preference for any particular organization. The organizations in this list are not the only ones that might be able to help you.

PREPARING FOR TREATMENT

What is VABYSMO?

VABYSMO (faricimab-svoa) is a prescription medicine given by injection into the eye used to treat adults with neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO).

Do not receive VABYSMO if you:

Have an infection in or around your eye.
Have active swelling around your eye that may include pain and redness.
Are allergic to VABYSMO or any of the ingredients in VABYSMO.

What is the most important information I should know about VABYSMO?

Injections like the one for VABYSMO can cause an eye infection (endophthalmitis), separation of layers of the retina (retinal detachment), or inflammation in the eye that can lead to vision loss. Call your healthcare provider right away if your eye becomes red, sensitive to light, or you have a change or loss of vision.
VABYSMO may cause a temporary increase in pressure in the eye (intraocular pressure), which occurs within 60 minutes after receiving the eye injection.
Although not common, VABYSMO patients have had serious, sometimes fatal, problems related to blood clots, such as heart attacks or strokes (thromboembolic events). In clinical studies for wet AMD during the first year, 7 out of 664 patients treated with VABYSMO reported such an event. In clinical studies for DME from baseline to week 100, 64 out of 1,262 patients treated with VABYSMO reported such an event. In clinical studies for RVO during 6 months, 7 out of 641 patients treated with VABYSMO reported such an event.
Severe inflammation of vessels in the retina has happened for patients treated with VABYSMO. Call your healthcare provider immediately if you experience a change in vision.

Before receiving VABYSMO, tell your healthcare provider about all of your medical conditions, including if you:

Are pregnant or plan to become pregnant. Based on how VABYSMO interacts with your body, there may be a potential risk to your unborn baby. You should use birth control before your first injection, during your treatment with VABYSMO, and for 3 months after your last dose of VABYSMO.
Are breastfeeding or plan to breastfeed. It is not known if VABYSMO passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you receive VABYSMO.
Are taking any medications, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Tell your healthcare provider about all the medicines you take.

What should I avoid while receiving VABYSMO?

Your vision may be impaired after receiving an eye injection or after an eye exam. Do not drive or use machinery until your vision has recovered sufficiently.

What are the most common side effects with VABYSMO?

The most common side effects with VABYSMO were cataract and blood on the white of the eye (conjunctival hemorrhage).
These are not all the possible side effects of VABYSMO.

Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Genentech at 1-888-835-2555.

Please see the VABYSMO full Prescribing Information for additional Important Safety Information.